Co-Diagnostics, Inc. to Present at 15th Next Generation Dx Summit in Washington, D.C.

SALT LAKE CITY, Aug. 18, 2023 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be sponsoring, presenting and hosting a booth at the 15th Annual Next Generation Dx Summit, held virtually and in-person in … Read more